Ancizu, S.; Moreno, E.; Torres, E.; Burguete, A.; Pérez-Silanes, S.; Benítez, D.; Villar, R.; Solano, B.; Marín, A.; Aldana, I.;
et al. Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs. Molecules 2009, 14, 2256-2272.
https://doi.org/10.3390/molecules14062256
AMA Style
Ancizu S, Moreno E, Torres E, Burguete A, Pérez-Silanes S, Benítez D, Villar R, Solano B, Marín A, Aldana I,
et al. Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs. Molecules. 2009; 14(6):2256-2272.
https://doi.org/10.3390/molecules14062256
Chicago/Turabian Style
Ancizu, Saioa, Elsa Moreno, Enrique Torres, Asunción Burguete, Silvia Pérez-Silanes, Diego Benítez, Raquel Villar, Beatriz Solano, Adoración Marín, Ignacio Aldana,
and et al. 2009. "Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs" Molecules 14, no. 6: 2256-2272.
https://doi.org/10.3390/molecules14062256
APA Style
Ancizu, S., Moreno, E., Torres, E., Burguete, A., Pérez-Silanes, S., Benítez, D., Villar, R., Solano, B., Marín, A., Aldana, I., Cerecetto, H., González, M., & Monge, A.
(2009). Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs. Molecules, 14(6), 2256-2272.
https://doi.org/10.3390/molecules14062256
